Summit Therapeutics SMMT
NASDAQ SMMT
$16.40 +0.92 (+5.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Asset Writedowns and Impairment (2020 - 2023)

Updated

Summit Therapeutics (SMMT) reported Asset Writedowns and Impairment of $474,000 for FY2023, down 94.4% from $8.47 million in FY2022.

Analysis

Summit Therapeutics (SMMT) Asset Writedowns and Impairment (2020 - 2023) Analysis & Trends

Dating back to FY2018, Summit Therapeutics' Asset Writedowns and Impairment record includes 4 years.

  • Asset Writedowns and Impairment has a five-year compound annual growth rate of -38.3% (FY2018 to FY2023).
  • According to Business Quant data, Asset Writedowns and Impairment came in at $8.47 million in FY2022 and $859,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Summit Therapeutics 12.28 Bn 10.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 474,000.00
Dec 31, 2022 8.47 Mn
Sep 30, 2020 859,000.00
API Access

Summit Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SMMT&period=max&api_key=YOUR_API_KEY